BROWSE

Related Scientist

hwang,daehee's photo.

hwang,daehee
식물노화·수명연구단
more info

ITEM VIEW & DOWNLOAD

Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation

DC Field Value Language
dc.contributor.authorHong S.W.-
dc.contributor.authorHur W.-
dc.contributor.authorChoi J.E.-
dc.contributor.authorKim J.-H.-
dc.contributor.authorDaehee Hwang-
dc.contributor.authorYoon S.K.-
dc.date.available2016-06-27T05:01:01Z-
dc.date.created2016-06-20ko
dc.date.issued2016-04-
dc.identifier.issn1949-2553-
dc.identifier.urihttps://pr.ibs.re.kr/handle/8788114/2575-
dc.description.abstractWe investigated the biological role of CD133-expressing liver cancer stem cells (CSCs) enriched after irradiation of Huh7 cells in cell invasion and migration. We also explored whether a disintegrin and metalloproteinase-17 (ADAM17) influences the metastatic potential of CSC-enriched hepatocellular carcinoma (HCC) cells after irradiation. A CD133-expressing Huh7 cell subpopulation showed greater resistance to sublethal irradiation and specifically enhanced cell invasion and migration capabilities. We also demonstrated that the radiation-induced MMP-2 and MMP-9 enzyme activities as well as the secretion of vascular endothelial growth factor were increased more predominantly in Huh7CD133+ cell subpopulations than Huh7CD133- cell subpopulations. Furthermore, we showed that silencing ADAM17 significantly inhibited the migration and invasiveness of enriched Huh7CD133+ cells after irradiation; moreover, Notch signaling was significantly reduced in irradiated CD133-expressing liver CSCs following stable knockdown of the ADAM17 gene. In conclusion, our findings indicate that CD133-expressing liver CSCs have considerable metastatic capabilities after irradiation of HCC cells, and their metastatic capabilities might be maintained by ADAM17. Therefore, suppression of ADAM17 shows promise for improving the efficiency of current radiotherapies and reducing the metastatic potential of liver CSCs during HCC treatment.-
dc.description.uri1-
dc.language영어-
dc.publisherIMPACT JOURNALS LLC-
dc.subjectADAM17-
dc.subjectCancer stem cells-
dc.subjectHepatocellular carcinoma-
dc.subjectMigration-
dc.subjectRadioresistance-
dc.titleRole of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation-
dc.typeArticle-
dc.type.rimsART-
dc.identifier.wosid000377706200039-
dc.identifier.scopusid2-s2.0-84966570653-
dc.identifier.rimsid55858ko
dc.date.tcdate2018-10-01-
dc.contributor.affiliatedAuthorDaehee Hwang-
dc.identifier.doi10.18632/oncotarget.8112-
dc.identifier.bibliographicCitationONCOTARGET, v.7, no.17, pp.23482 - 23497-
dc.citation.titleONCOTARGET-
dc.citation.volume7-
dc.citation.number17-
dc.citation.startPage23482-
dc.citation.endPage23497-
dc.date.scptcdate2018-10-01-
dc.description.wostc8-
dc.description.scptc15-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.subject.keywordPlusENDOTHELIAL GROWTH-FACTOR-
dc.subject.keywordPlusEPITHELIAL-MESENCHYMAL TRANSITION-
dc.subject.keywordPlusHUMAN HEPATOCELLULAR-CARCINOMA-
dc.subject.keywordPlusBREAST-CANCER-
dc.subject.keywordPlusDEFINITIVE RADIOTHERAPY-
dc.subject.keywordPlusNOTCH PATHWAY-
dc.subject.keywordPlusTUMOR-GROWTH-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordPlusMETASTASIS-
dc.subject.keywordPlusRADIORESISTANCE-
dc.subject.keywordAuthorcancer stem cells-
dc.subject.keywordAuthorhepatocellular carcinoma-
dc.subject.keywordAuthorradioresistance-
dc.subject.keywordAuthorADAM17-
dc.subject.keywordAuthormigration-
Appears in Collections:
Center for Plant Aging Research (식물 노화·수명 연구단) > 1. Journal Papers (저널논문)
Files in This Item:
9.Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation.pdfDownload

qrcode

  • facebook

    twitter

  • Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse